Novel biallelic USH2A variants in a patient with usher syndrome type IIA- a case report

• Published in: BMC ophthalmology Vol. 22; no. 1; p. 140
• Main Authors: Young, Su Ling, Stanton, Chloe M, Livesey, Benjamin J, Marsh, Joseph A, Cackett, Peter D
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26.03.2022; BioMed Central; BMC
• Subjects: Acuity; Adolescent; Age; Amino acids; Blindness; Case Report; Case reports; Cataracts; Codon; Codon, Nonsense; Deafness; Diagnosis; Extracellular Matrix Proteins - genetics; Female; Genes; Genetic aspects; Genetic diversity; Genetic screening; Hearing loss; Humans; Inherited retinal disease; Laboratories; Middle Aged; Missense mutation; Mutation; Mutation, Missense; Nonsense mutation; Novel mutation; Ophthalmology; Pathogenicity; Patients; Proteins; Teenagers; USH2A; USH2A protein; Usher syndrome type IIA; Usher Syndromes - diagnosis; Usher Syndromes - genetics; Visual field; United Kingdom; United Kingdom > UK; Pathogenicity; Case report; USH2A; Inherited retinal disease; Novel mutation; Usher syndrome type IIA
• ISSN: 1471-2415; 1471-2415
• DOI: 10.1186/s12886-022-02353-7

Usher Syndrome is the commonest cause of inherited blindness and deafness. The condition is clinically and genetically heterogeneous, with no current treatment. We report a case carrying novel biallelic variants in USH2A causing progressive early adolescent onset visual and hearing impairment consistent with Usher Syndrome Type IIA. Our patient presented at age 13 with progressive visual field loss and hearing loss, associated with early onset of cataract in her 40s requiring lens extraction. Now 52 years old, latest best corrected visual acuity (BCVA) stands at Logmar Right Eye (RE) 0.8 and Left Eye (LE) 0.2, with significantly constricted visual fields bilaterally. She was registered partially sighted age 46. Clinical and molecular genetic assessment of the proband was consistent with a diagnosis of Usher Syndrome Type IIA. Genetic testing identified two novel USH2A variants, resulting in the premature termination codon p.Leu30Ter and a missense mutation p.Cys3251Tyr. Segregation analysis confirmed that these variants were biallelic in the affected case. Comprehensive in silico analysis confirmed that these mutations are the probable cause of Usher Syndrome Type IIA in this individual. The identification of novel mutations in USH2A increases the spectrum of genetic variations that lead to Usher Syndrome, aiding genetic diagnosis, assessment of patient prognosis, and emphasising the importance of genetic testing to identify new mutations in patients with undiagnosed progressive visual loss.